Efficacy of quadratus lumborum block III (QLB III) after total hip arthroplasty (THA) surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201701001969162

Enrollment

Registered

2017-01-13

Start date

2017-01-16

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases Surgery total hip arthroplasty

Interventions

Quadratus lumborum block type III

Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patient aged 18 or more elective total hip arthroplasty

Exclusion criteria

Exclusion criteria: revision arthroplasty traumatic arthroplasty steroid intake contra-indication of NSAI's consent refusal block refusal

Design outcomes

Primary

Measure	Time frame
morphine consumption	—

Secondary

Measure	Time frame
Pain scores	—

Countries

Tunisia

Contacts

Public ContactOlfa Kaabachi

Institut Mohamed Kassab d'Orthopédie, Department of anesthesiology and intensive care

olfa.kaabachi@gnet.tn0021698317381

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026